Evidence map›Paper›PMID 34984522›Full record

ArticleNeuroradiology2022

Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study.

R H G J van Lanen, C J Wiggins, A J Colon, W H Backes, J F A Jansen, D Uher, G S Drenthen, A Roebroeck, D Ivanov, B A Poser and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Neuroradiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 2 countries.

R H G J van LanenDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands. rick.van.lanen@mumc.nl.
C J WigginsScannexus, Ultra-High Field MRI Research Center, Maastricht, the Netherlands.
A J ColonAcademic Centre for Epileptology, Kempenhaeghe/Maastricht University Medical Center, Heeze/Maastricht, the Netherlands.
W H BackesSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
J F A JansenSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
D UherSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
G S DrenthenSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
A RoebroeckDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.
D IvanovDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.
B A PoserDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.
M C HoeberigsSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
S M J van KuijkDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, Maastricht, the Netherlands.
G HooglandDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands.
K RijkersDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands.
G L WagnerAcademic Centre for Epileptology, Kempenhaeghe/Maastricht University Medical Center, Heeze/Maastricht, the Netherlands.
J BeckervordersandforthDepartment of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands.
D DelevDepartment of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.
H ClusmannDepartment of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.
S WolkingDepartment of Epileptology and Neurology, RWTH Aachen University Hospital, Aachen, Germany.
S KlinkenbergSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
R P W RouhlSchool for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
P A M HofmanAcademic Centre for Epileptology, Kempenhaeghe/Maastricht University Medical Center, Heeze/Maastricht, the Netherlands.
O E M G SchijnsDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands.
Maastricht University · NLKempenhaeghe · NLUniversitätsklinikum Aachen · DE

Funding

Epilepsiefonds WAR project number 2020-09
6 · The paper itself

Abstract

purposeResective epilepsy surgery is a well-established, evidence-based treatment option in patients with drug-resistant focal epilepsy. A major predictive factor of good surgical outcome is visualization and delineation of a potential epileptogenic lesion by MRI. However, frequently, these lesions are subtle and may escape detection by conventional MRI (≤ 3 T).

methodsWe present the EpiUltraStudy protocol to address the hypothesis that application of ultra-high field (UHF) MRI increases the rate of detection of structural lesions and functional brain aberrances in patients with drug-resistant focal epilepsy who are candidates for resective epilepsy surgery. Additionally, therapeutic gain will be addressed, testing whether increased lesion detection and tailored resections result in higher rates of seizure freedom 1 year after epilepsy surgery. Sixty patients enroll the study according to the following inclusion criteria: aged ≥ 12 years, diagnosed with drug-resistant focal epilepsy with a suspected epileptogenic focus, negative conventional 3 T MRI during pre-surgical work-up.

resultsAll patients will be evaluated by 7 T MRI; ten patients will undergo an additional 9.4 T MRI exam. Images will be evaluated independently by two neuroradiologists and a neurologist or neurosurgeon. Clinical and UHF MRI will be discussed in the multidisciplinary epilepsy surgery conference. Demographic and epilepsy characteristics, along with postoperative seizure outcome and histopathological evaluation, will be recorded.

conclusionThis protocol was reviewed and approved by the local Institutional Review Board and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Results will be submitted to international peer-reviewed journals and presented at international conferences. TRIAL REGISTRATION NUMBER: www.trialregister.nl : NTR7536.

Indexed as

Drug Resistant EpilepsyEpilepsies, PartialMagnetic Resonance ImagingChildHumansLongitudinal StudiesProspective StudiesTreatment Outcome7 T9.4 TEpilepsyEpilepsy surgeryUHF MRI

Identifiers

PMID34984522
PMCPMC8907090
OpenAlexW4205907693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.